2011
DOI: 10.1111/j.1525-1470.2011.01426.x
|View full text |Cite
|
Sign up to set email alerts
|

Livedo Reticularis: A Side Effect of Interferon Therapy in a Pediatric Patient with Melanoma

Abstract: Livedo reticularis is a lacy mottling of the skin that can have many etiologies. We report a case of an 8-year-old boy with a diagnosis of melanoma who developed persistent livedo reticularis during treatment with interferon alpha-2B. To our knowledge, this is the first case report of livedo reticularis occurring as a side effect of interferon treatment for pediatric melanoma. Given the increasing incidence of pediatric melanoma, it is important that dermatologists be aware of potential side effects of interfe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…79 Another report in an 8-year-old boy receiving IFN-α for melanoma describes drug-induced persistent livedo reticularis, with a lacy, red-purple, mottled eruption appearing on the legs 3 months after therapy initiation. 80 Self-limited alopecia is common during IFN treatment for hepatitis B. 81…”
Section: Ifn-α Stimulates T Cells and Natural Killer Cells And Is Antmentioning
confidence: 99%
“…79 Another report in an 8-year-old boy receiving IFN-α for melanoma describes drug-induced persistent livedo reticularis, with a lacy, red-purple, mottled eruption appearing on the legs 3 months after therapy initiation. 80 Self-limited alopecia is common during IFN treatment for hepatitis B. 81…”
Section: Ifn-α Stimulates T Cells and Natural Killer Cells And Is Antmentioning
confidence: 99%